Home › RegulatoryADARx Pharmaceuticals, Inc. - 10-Q FilingADARx Pharmaceuticals reports quarterly results for the period ended September 30, 2026SEC EDGAR · November 12, 2026, 21:15 UTCTickers: $ADRX Read the full article at SEC EDGAR